Annual Revenue
N/A
December 31, 2023
Summary
- LSTA annual revenue is not available.
Performance
LSTA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- LSTA quarterly revenue is not available.
Performance
LSTA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- LSTA TTM revenue is not available.
Performance
LSTA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
LSTA Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
LSTA Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time |
Lisata Therapeutics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | $7.49 M(-0.9%) | $26.80 M(+19.2%) |
Dec 2015 | $22.49 M(+25.4%) | $7.56 M(+28.4%) | $22.49 M(+11.3%) |
Sep 2015 | - | $5.89 M(+0.4%) | $20.20 M(+9.6%) |
Jun 2015 | - | $5.87 M(+85.0%) | $18.43 M(+8.1%) |
Mar 2015 | - | $3.17 M(-39.9%) | $17.06 M(-4.9%) |
Dec 2014 | $17.94 M(+22.3%) | $5.28 M(+28.1%) | $17.94 M(+7.2%) |
Sep 2014 | - | $4.12 M(-8.3%) | $16.74 M(+2.5%) |
Jun 2014 | - | $4.49 M(+10.7%) | $16.33 M(+0.8%) |
Mar 2014 | - | $4.06 M(-0.6%) | $16.20 M(+10.4%) |
Dec 2013 | $14.67 M(+2.4%) | $4.08 M(+10.0%) | $14.67 M(+9.9%) |
Sep 2013 | - | $3.71 M(-15.0%) | $13.34 M(-5.2%) |
Jun 2013 | - | $4.36 M(+72.7%) | $14.07 M(+7.5%) |
Mar 2013 | - | $2.52 M(-8.3%) | $13.08 M(-8.7%) |
Dec 2012 | $14.33 M(+42.6%) | $2.75 M(-38.0%) | $14.33 M(-9.3%) |
Sep 2012 | - | $4.43 M(+31.5%) | $15.79 M(+16.7%) |
Jun 2012 | - | $3.37 M(-10.6%) | $13.53 M(+9.4%) |
Mar 2012 | - | $3.77 M(-10.5%) | $12.37 M(-56.1%) |
Dec 2011 | $10.05 M(-85.6%) | $4.21 M(+93.5%) | $28.19 M(-33.0%) |
Sep 2011 | - | $2.18 M(-1.5%) | $42.08 M(-25.4%) |
Jun 2011 | - | $2.21 M(-88.7%) | $56.38 M(-23.4%) |
Mar 2011 | - | $19.59 M(+8.2%) | $73.58 M(+5.4%) |
Dec 2010 | $69.82 M(+503.7%) | $18.11 M(+9.9%) | $69.82 M(+10.6%) |
Sep 2010 | - | $16.48 M(-15.1%) | $63.12 M(+35.1%) |
Jun 2010 | - | $19.41 M(+22.6%) | $46.73 M(+70.8%) |
Mar 2010 | - | $15.83 M(+38.8%) | $27.36 M(+136.5%) |
Dec 2009 | $11.57 M(>+9900.0%) | $11.41 M(>+9900.0%) | $11.57 M(+5805.7%) |
Sep 2009 | - | $85.10 K(+169.3%) | $195.90 K(+44.0%) |
Jun 2009 | - | $31.60 K(-29.9%) | $136.00 K(+6.3%) |
Mar 2009 | - | $45.10 K(+32.3%) | $127.90 K(+53.2%) |
Dec 2008 | $83.50 K | $34.10 K(+35.3%) | $83.50 K(-59.6%) |
Sep 2008 | - | $25.20 K(+7.2%) | $206.60 K(+6.5%) |
Jun 2008 | - | $23.50 K(+3257.1%) | $194.00 K(+9.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2008 | - | $700.00(-99.6%) | $176.50 K(-23.8%) |
Dec 2007 | $231.70 K(+407.0%) | $157.20 K(+1147.6%) | $231.70 K(+128.5%) |
Sep 2007 | - | $12.60 K(+110.0%) | $101.40 K(+6.6%) |
Jun 2007 | - | $6000.00(-89.3%) | $95.10 K(-0.3%) |
Mar 2007 | - | $55.90 K(+107.8%) | $95.40 K(+108.3%) |
Dec 2006 | $45.70 K(+29.5%) | $26.90 K(+327.0%) | $45.80 K(+76.2%) |
Sep 2006 | - | $6300.00(0.0%) | $26.00 K(-6.8%) |
Jun 2006 | - | $6300.00(0.0%) | $27.90 K(-10.0%) |
Mar 2006 | - | $6300.00(-11.3%) | $31.00 K(-11.9%) |
Dec 2005 | $35.30 K(-27.4%) | $7100.00(-13.4%) | $35.20 K(-10.4%) |
Sep 2005 | - | $8200.00(-12.8%) | $39.30 K(+15.2%) |
Jun 2005 | - | $9400.00(-10.5%) | $34.10 K(+7.2%) |
Mar 2005 | - | $10.50 K(-6.3%) | $31.80 K(-34.6%) |
Dec 2004 | $48.60 K(-24.8%) | $11.20 K(+273.3%) | $48.60 K(-6.0%) |
Sep 2004 | - | $3000.00(-57.7%) | $51.70 K(-19.2%) |
Jun 2004 | - | $7100.00(-74.0%) | $64.00 K(-13.4%) |
Mar 2004 | - | $27.30 K(+90.9%) | $73.90 K(+14.4%) |
Dec 2003 | $64.60 K(-20.5%) | $14.30 K(-6.5%) | $64.60 K(-6.1%) |
Sep 2003 | - | $15.30 K(-10.0%) | $68.80 K(-6.4%) |
Jun 2003 | - | $17.00 K(-5.6%) | $73.50 K(-1.7%) |
Mar 2003 | - | $18.00 K(-2.7%) | $74.80 K(-8.1%) |
Dec 2002 | $81.30 K(-24.3%) | $18.50 K(-7.5%) | $81.40 K(-22.7%) |
Sep 2002 | - | $20.00 K(+9.3%) | $105.30 K(-10.9%) |
Jun 2002 | - | $18.30 K(-25.6%) | $118.20 K(-2.1%) |
Mar 2002 | - | $24.60 K(-42.0%) | $120.70 K(+12.2%) |
Dec 2001 | $107.40 K(+294.9%) | $42.40 K(+28.9%) | $107.60 K(+27.6%) |
Sep 2001 | - | $32.90 K(+58.2%) | $84.30 K(+64.0%) |
Jun 2001 | - | $20.80 K(+80.9%) | $51.40 K(-20.8%) |
Mar 2001 | - | $11.50 K(-39.8%) | $64.90 K(+18.2%) |
Dec 2000 | $27.20 K(+6700.0%) | $19.10 K(-44.3%) | $54.90 K(+53.4%) |
Jun 2000 | - | $34.30 K(+2186.7%) | $35.80 K(+2286.7%) |
Mar 2000 | - | $1500.00 | $1500.00 |
Dec 1999 | $400.00 | - | - |
FAQ
- What is the all time high annual revenue for Lisata Therapeutics?
- What is the all time high quarterly revenue for Lisata Therapeutics?
- What is the all time high TTM revenue for Lisata Therapeutics?
What is the all time high annual revenue for Lisata Therapeutics?
Lisata Therapeutics all-time high annual revenue is $69.82 M
What is the all time high quarterly revenue for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly revenue is $19.59 M
What is the all time high TTM revenue for Lisata Therapeutics?
Lisata Therapeutics all-time high TTM revenue is $73.58 M